Blood cancer characteristics and outcomes study
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at the health and treatment results of adults with blood cancers at Assiut University. By tracking your progress, researchers hope to learn more about these diseases and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a blood cancer (also called a hematological malignancy).
- Your cancer diagnosis and treatment must have been started at Assiut University (not elsewhere).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who are being checked for a possible blood cancer, or who were recently diagnosed with a blood cancer within the last 6 months. It may help doctors understand the condition better and improve how early workups and care are organized.
This study looks at how well treatment works for people with blood cancers who receive a stem cell transplant using their own stem cells. It helps doctors understand the experience and outcomes in Upper Egypt.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
This is a registry (a study that collects health information over time) for adults with suspected or confirmed blood cancers of the myeloid type. It aims to better understand the biology of these illnesses and how different factors affect outcomes, which may improve care in the future.
This study collects blood and bone marrow samples from patients with blood cancers to understand why treatments stop working. It aims to improve future treatments.
This study looks at whether a simple blood test can help predict how well a person with a blood cancer like leukemia, lymphoma, or multiple myeloma might do. It aims to find a new biomarker that could guide treatment decisions.
Hear when a new Haematologic Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.